2nd
The Alliance for mRNA Medicines (AMM) brings together senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients. The annual meeting, AMM ASCENT (Advancements in mRNA Science, Commercialiation, Education, and Novel Technologies), features one-on-one partnering opportunities for companies and investors, dedicated networking, keynotes and fireside chats featuring KOLs and industry visionaries, as well as engaging plenary and panel discussions among biotech, pharma, and academic leaders.
September 16-18, 2025
Coronado Island Marriott Resort and Spa
1500 Orange Ave, Coronado, CA 92118
Through the power of the partneringONE partnering platform, attendees can search, connect, and schedule 1:1 meetings with potential partners to identify opportunities, build relationships, and move deals forward.
Ample dedicated networking opportunies to connect with other industry leaders and potential partners.
Learn from senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients with engaging speakers, fireside chats, and panel discussions.
Our sessions will feature some of the leading voices in the mRNA industry, sharing their unique insights and expertise. Currently confirmed speakers include:
Director, Center for Biologics Evaluation and Research, FDA
Deputy Center Director, Center for Biologics Evaluation and Research, FDA
Chief Development Officer and Co-Founder, Replicate Bioscience
Director of Process Development, Curia
Vice President, Process Development & RNA Technology, Verve Therapeutics
Bloomberg Distinguished Professor of RNA Biology and Therapeutics, Johns Hopkins University
President, Society for RNA Therapeutics; Professor & Chair, Dept. of Cardiovascular Sciences, Houston Methodist Hospital and Academic Institute
Managing Director, Matrix Capital Management Company, L.P.
Chief Technology Officer & Global Head of Research, mRNA Center of Excellence, Sanofi
Chief Strategy Officer, Arcturus
CEO and Co-Founder, Sensible Biotechnologies
Portfolio Manager, Regulated Markets, New England Biolabs
Senior Vice President, Corporate Affairs, ReCode
Strategic Customer Leader – NanoMedicines, Cytiva
Senior Vice President, Business and Corporate Development, ReCode
CSO/CTO, Danaher Genomic Medicines
SVP of RNA Biochemistry and Manufacturing, BioNTech
Chief Strategy Officer and Co-Founder, Nanovation Therapeutics
President, Project Farma and Precision ADVANCE
Biotech Sector Lead, Private Equity, Wellington
President and CEO, MaxCyte
Founder and CEO, Cytonus
CEO, Sail Biomedicines
Managing Director, Capitol Street
Senior Director of Innovation & Strategy, Aldevron
Site Leader, mRNA, Thermo Fischer Scientific
Chief Scientific Officer, Acuitas
Senior Research Analyst, Piper Sandler
Head of Nucleic Acid Development, ReciBioPharm
State of the Industry & Global Policy Outlook Panel
State of the Industry & Global Policy Outlook Panel
Tuesday Keynote Address
Conference Sessions
mRNA and Cancer Immunotherapies
Future of AI in mRNA Development
Large Cap/Biopharm’s Role in mRNA Commercialization
Coffee Break
Sector Data Presentation
3 15-Minute Company Presentations
Conference Sessions
Scientific Panel Update
Wednesday Keynote Address
3 15-Minute Company Presentations
Regulatory Outlook Panel
The Future of mRNA in Gene Editing and Rare Disease
Manufacturing, CMC, and Analytics
3 15-Minute Company Presentations
Conference Sessions
Investor Panel
mRNA Delivery Innovation Panel
Coffee Break
TBD Panel
Our mRNA Future
Partnering is different from networking! It’s planning to meet because you have something to discuss rather than finding something to discuss because you happen to meet. Successful partnering is tied to pre-event preparation. With the support of EBD Group’s partneringONE™, arranging one-to-one meetings with your target companies is a breeze.
AMM is grateful to the partners whose support is making AMM ASCENT possible. Interested in becoming a sponsor? Contact [email protected] to learn more and check out our sponsor prospectus here.
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.